Market Trends of Middle East and Africa Lipids Industry
This section covers the major market trends shaping the MEA Lipids Market according to our research experts:
Rising Demand of Medium Chain Triglycerides
MCTs are used along with usual medications for treating food absorption disorders, including diarrhea, steatorrhea (fat indigestion), celiac disease, liver disease, and digestion problems, due to partial surgical removal of the stomach (gastrectomy) or the intestine (short bowel syndrome). Athletes, sometimes, use MCTs for nutritional support during training and for decreasing body fat and increasing lean muscle mass. Thus, an increased supply of medium-chain triglycerides (MCT) is particularly important in patients with disturbances of digestion and absorption, such as disturbed bile secretion, classic celiac disease, short bowel syndrome, inflammatory diseases of the intestines, the disturbed outflow of lymph, some metabolic disease, and severe food allergies, as well as in prematurely born neonates.
Pharmaceuticals is the Fastest Growing Segment
Currently, most of the pharmaceutical products are based on fish oil formulation in the market.Omega-3 approved drugs from Vascepa contains 4g/day of EPA. For getting the same from dietary supplements, one will need to purchase a 10-40 omega-3 supplement capsule. The applications of omega-3 ingredients in pharmaceuticals have a niche market, as there are very few players, who are at a market entry stage. Many of them are still in the research and trial process for product formulation with algae omega-3 oil. The application of omega-3 ingredients in pharmaceutical products accounts for about 27% of the market. Algae EPA and DHA for drug formulation are the safest sources of omega-3 oil, due to their high purity and sensory profile than other omega-3 sources.
